Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer’s disease patients: Long-term safety evaluation

    Recruiting

    3 1 1
    Bulgaria Croatia Czechia France Greece Hungary +5
  • A study testing trontinemab compared to placebo in patients with early Alzheimer’s disease including mild cognitive impairment and mild dementia

    Recruiting

    3 1 1
    Denmark France Germany Italy Poland Spain
  • Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer’s Disease

    Recruiting

    3 1 1
    Denmark France Germany Italy The Netherlands Poland +1
  • A study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer’s disease

    Recruiting

    3 1
    Investigated diseases:
    Czechia France Hungary Italy Poland
  • Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer’s disease

    Recruiting

    3 1
    Investigated diseases:
    Finland France Germany Greece Italy The Netherlands +4
  • Study of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer’s disease patients

    Recruiting

    3 1
    Investigated diseases:
    Bulgaria Croatia Greece Portugal Romania Spain
  • Using [18F]DED PET imaging to study brain changes in patients with Alzheimer’s disease, CADASIL, and other forms of dementia.

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study of flortaucipir and florbetapir in patients with memory disorders including Alzheimer’s disease and dementia

    Recruiting

    4 1 1 1
    France
  • Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer’s disease

    Recruiting

    3 1
    Croatia Czechia Germany Greece Italy Poland +2
  • Study of MK-2214 to slow disease progression in people with early Alzheimer’s disease

    Recruiting

    2 1
    Investigated drugs:
    Belgium The Netherlands Spain